Photodynamic therapy enhances liposomal doxorubicin distribution in tumors during isolated perfusion of rodent lungs
Background: Photodynamic therapy (PDT) at low drug-light conditions can enhance the transport of intravenously injected macromolecular therapeutics through the tumor vasculature. Here we determined the impact of PDT on the distribution of liposomal doxorubicin (Liporubicin™) administered by isolated lung perfusion (ILP) in sarcomas grown on rodent lungs. Methods: A syngeneic methylcholanthrene-induced sarcoma cell line was implanted subpleurally in the left lung of Fischer rats. Treatment schemes consisted in ILP alone (400 μg of Liporubicin), low-dose (0.0625 mg/kg Visudyne®, 10 J/cm 2 and 35 mW/cm 2) and high-dose left lung PDT (0.125 mg/kg Visudyne, 10 J/cm 2 and 35 mW/cm 2) followed by ILP (400 μg of Liporubicin). The uptake and distribution of Liporubicin in tumor and lung tissues were determined by high-performance liquid chromatography and fluorescence microscopy in each group. Results: Low-dose PDT significantly improved the distribution of Liporubicin in tumors compared to high-dose PDT (p < 0.05) and ILP alone (p < 0.05). However, both PDT pretreatments did not result in a higher overall drug uptake in tumors or a higher tumor-to-lung drug ratio compared to ILP alone. Conclusions: Intraoperative low-dose Visudyne-mediated PDT enhances liposomal doxorubicin distribution administered by ILP in sarcomas grown on rodent lungs which is predicted to improve tumor control by ILP. Copyright © 2011 S. Karger AG, Basel.
Keywords: Experimental study ; Isolated lung perfusion ; Lung ; Animal model ; Microcirculation ; Malignant Pleural Mesothelioma ; Pulmonary Metastases ; Vascular Normalization ; Phase-I ; Sarcoma ; Model ; Pharmacokinetics ; Verteporfin ; Cancer ; Trial
Record created on 2012-05-03, modified on 2016-08-09